Search

everythinglearnresearchcommunity

for

Search:↓

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Microneedling with either platelet-rich plasma or 5% minoxidil can increase hair growth in people with androgenetic alopecia, but minoxidil might be slightly better.

Digital imaging can effectively evaluate the donor area for hair transplants, showing variations in hair density and grouping by age and severity of hair loss.

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

UBM helps hair regrowth in men and women with hair loss.

Oral cyclosporin doesn't stop hair loss.

Invasive treatments can improve hair growth, but effectiveness varies and more research is needed.

Combining exosomes with microneedling may improve hair growth in androgenetic alopecia.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

Topical 5% minoxidil is effective and safe for treating androgenetic alopecia, especially in younger patients with early-stage hair loss.

Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

Diffuse alopecia in females is often linked to certain medications, diseases, and low hemoglobin, while female pattern hair loss is linked to age, duration, and family history.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Experts created guidelines for treating hair loss in Egypt, focusing on personalized care.

Low-dose oral minoxidil is effective and safe for hair loss, but more research is needed.

Unani medicine offers a natural, effective approach to treating hair loss with minimal side effects, but needs more scientific validation.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Wet cupping may improve hair health in androgenetic alopecia without side effects.

Placental stem cell exosome therapy improves hair growth and reduces hair loss.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.